This site is intended for healthcare professionals
Drug news

Bayer files MAA at EMA for larotrectinib to treat locally advanced or metastatic solid tumors with NTRK gene fusion.- Loxo Oncology + Bayer HealthCare.

Read time: 1 mins
Last updated:28th Aug 2018
Published:28th Aug 2018
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest